In a first step, the drugs were assessed on 3 human meningioma cell lines, 2 with NF2 deficiency (Ben-Men-1, CH-157MN) and one without (IOMM-Lee). This evidence concerns the gene NF2 and hyperinsulinemic hypoglycemia, familial, 4.